BASEL, Switzerland, Feb. 27, 2017 /PRNewswire/ -- Axovant Sciences (NYSE: AXON), a leading clinical-stage biopharmaceutical company focused on the treatment of dementia, today announced upcoming presentations at three investor conferences:
- March 6 at 3:20 p.m. ET at the Cowen and Company 37th Annual Healthcare Conference
- March 14 at 10:45 a.m. ET at the Barclays Global Healthcare Conference
- March 22 at 3:55 p.m. ET at the Oppenheimer 27th Annual Healthcare Conference
A simultaneous webcast will be available for each conference in the Investors section of Axovant's website at www.axovant.com. A replay will be available for 30 days following each conference.